Presentation title at-a-glance info (in slide master) Introduction to the Gavi CSO Platforms Project

Similar documents
Gavi s strategic framework 22 June 2016

1) SO1: We would like to suggest that the indicator used to measure vaccine hesitancy be DTP 1 to measles first dose dropout.

FP2020 Expert Advisory Community Webinar

POLIOMYELITIS ERADICATION: PROGRESS REPORT. Information Document CONTENTS BACKGROUND PROGRESS MADE NEXT STEPS... 12

What is this document and who is it for?

Malaria Funding. Richard W. Steketee MACEPA, PATH. April World Malaria Day 2010, Seattle WA

COLD CHAIN EQUIPMENT OPTIMISATION PLATFORM (CCEOP)

PROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS

Update from GAVI Aurelia Nguyen

TT Procured by UNICEF

IMMUNIZATION VACCINES & EMERGENCIES

Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook. UNICEF Supply Division

Putting the recommendations into action

Global reductions in measles mortality and the risk of measles resurgence

Aboubacar Kampo Chief of Health UNICEF Nigeria

HPV Vaccine Lessons Learned & New Ways Forward

Health systems and HIV: advocacy. Interagency Coalition on AIDS and Development

Prioritizing Emergency Polio Eradication Activities

Status Report on WSS MDG Roadmaps and Country Status Overviews WSP Africa

Yellow fever laboratory capacity on-site assessments in Africa: preliminary findings

Update on Meningococcal A Vaccine Development and Introduction

CONTENTS. Paragraphs I. BACKGROUND II. PROGRESS REPORT ON THE AFRICAN REGIONAL IMMUNIZATION STRATEGIC PLAN

Highlights from the SUN Civil Society Network Annual Survey 2017 Img.1 SUNCSN Learning Route in Rwanda, Gisagara District

GAVI Alliance Board Meeting, 30 November 1 December 2010 Updates

Rotavirus Vaccine: Supply & Demand Update. UNICEF Supply Division

Update from the GAVI Alliance Seth Berkley, MD Chief Executive Officer

( A JICA-IRRI-PhilRice Initiative) Presented by Noel Magor, Head Unit Impact Acceleration and Training Center, IRRI

CDC s Commitment to National Laboratory Systems to Achieve Global Health Security

GAVI CSO Project Newsletter

Addressing Malaria in Pregnancy: A Comprehensive Approach to Maternal and Newborn Health Outcomes

Comparative Analyses of Adolescent Nutrition Indicators

PROGRESS REPORT ON THE ROAD MAP FOR ACCELERATING THE ATTAINMENT OF THE MILLENNIUM DEVELOPMENT GOALS RELATED TO MATERNAL AND NEWBORN HEALTH IN AFRICA

ASLM Anti-microbial Resistance in Africa and Global Health Security. 9TH INTEREST WORKSHOP May 2015 Harare

Full list of payments made to projects in 2017

IMMUNIZATION & VACCINE PREVENTABLE DISEASES

Expert Group Meeting on Strategies for Creating Urban Youth Employment: Solutions for Urban Youth in Africa

MEASLES ELIMINATION BY 2020: A STRATEGY FOR THE AFRICAN REGION. Report of the Secretariat. Executive Summary

IMMUNIZATION VACCINE DEVELOPMENT

Private Sector Opportunities to Support Family Planning and Access to Reproductive Health Services

Global Campaign to end Obstetric Fistula

AIDS in Africa. An Update. Basil Reekie

Funding for AIDS: The World Bank s Role. Yolanda Tayler, WB Bi-regional Workshop for the Procurement of ARVs Phnom Penh, Cambodia

TFI Proceedings, Recommendations and implications for 2005

Review of decisions Debbie Adams

Access to vaccination in GAVI countries and at global level

FRAMEWORK FOR IMPLEMENTING THE GLOBAL STRATEGY TO ELIMINATE YELLOW FEVER EPIDEMICS (EYE), IN THE AFRICAN REGION. Report of the Secretariat

Yellow fever Vaccine investment strategy

ANNEX Page. AFR/RC61/11 4 July 2011 ORIGINAL: ENGLISH REGIONAL COMMITTEE FOR AFRICA

Annex 2 A. Regional profile: West Africa

EXPLANATION OF INDICATORS CHOSEN FOR THE 2017 ANNUAL SUN MOVEMENT PROGRESS REPORT

Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005

Scaling Up Nutrition Action for Africa

IMMUNIZATION VACCINE DEVELOPMENT

Gender, Poverty, and Health in Sub-Saharan Africa: A Framework for Analysis

IMMUNIZATION VACCINE DEVELOPMENT

Fighting Harder and Smarter Against Malaria. Dr.Bernard Nahlen Deputy US Global Malaria Coordinator University of Georgia, February 23, 2010

Excellence and Originality from Necessity: Palliative Care in Africa. Dr Emmanuel Luyirika Executive Director, African Palliative Care Association

Sourcing of ARVs & HIV diagnostics. Procurement for Impact P4i

Gavi Unicef Vaccine Industry Consultation. Dominic Hein Market Shaping / Gavi. October Reach every child

Closing the loop: translating evidence into enhanced strategies to reduce maternal mortality

Report to the. GAVI Alliance Board November Stefano Malvolti, Paul Kelly, Mursaleena Islam

Presentation by Dr Philippe Douste-Blazy. Chair of UNITAID Special Representative of the UN SG for Innovative Financing for Development

CEO Board report Seth Berkley MD CEO

Ouagadougou Declaration

The Promise of Introducing Rubella Containing Vaccines on the Impact of Rubella and Measles Control

Content. Introduction. Overview of reported outbreaks in WHO African Region. Disease Surveillance and Response. Vol. 2 Issue 3, April 30, 2012

40 years of childhood vaccination programmes in Africa. Mind the gap

Measles Containing Vaccines

GAVI 5.0 THE ALLIANCE S STRATEGY

CEO Board report Seth Berkley MD CEO

GAVI S CONTINUED ROLE IN YELLOW FEVER CONTROL

Expert Group Meeting on the Regional Report for the African Gender and Development Index

GABON. Neglected tropical disease treatment report profile for mass treatment of NTDs

CANCER OF THE CERVIX IN THE AFRICAN REGION: CURRENT SITUATION AND WAY FORWARD

AFRICA. The continent of All challenges

UNAIDS 2013 AIDS by the numbers

For information on programmes in other countries and regions please access the Federation website at Programme title 2005

IMMUNIZATION VACCINE DEVELOPMENT

Overview of WHO/UNICEF Immunization Coverage Estimates

Measles Supplementary Immunization Activities and GAVI Funds as Catalysts for Improving Injection Safety in Africa

End Cervical Cancer: Prevent, Treat, Care

Global Malaria Initiative

GAVI RESOURCE GAP ALWAYS BEEN AN ISSUE

Plan of Presentation

Update on the Francophone PAC Secretariat

Development of the Polio Eradication and Endgame Strategic plan

POLIO ERADICATION IN THE AFRICAN REGION: PROGRESS REPORT. Information document EXECUTIVE SUMMARY

NO MORE MISSED MDG4 OPPORTUNITIES: OPTIMIZING EXISTING HEALTH PLATFORMS FOR CHILD SURVIVAL. Measles & Rubella Campaigns

Update on PMTCT. African Health Profession Regulatory Collaborative for Nurses and Midwives. Johannesburg, Republic of South Africa, June 18-22, 2012

Rotavirus vaccines: Issues not fully addressed in efficacy trials

GAVI Alliance Board Meeting, 30 November 1 December 2010 Update

PARTNERSHIP EGYPT KYRGYZ REPUBLIC. Photo by Jonathan Torgovnik _Getty Images Reportage_. 09/11/2018 Partnership Progress Report 2018

Africa s slow fertility transition

Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive

Wild Poliovirus Weekly Update

Optimizing Quality of Life through Palliative Care for Adults and Children affected by Cancer

Neglected Tropical Diseases

Maternal, Newborn and Child Health: Global initiatives and priority products for MNCH Dr. Mark W. Young Senior Health Specialist, UNICEF-New York

Report to the Board 7-8 December 2016

Food Production and Violent Conflict in Sub-Saharan Africa. - Supplementary Information -

Transcription:

Introduction to the Gavi CSO Platforms Project Raquel Fernandes Coordinator of the Oversight Advisory Group May 2018

Gavi CSO Constituency for Immunisation and Stronger Health Systems ~ 4000 Constituency members globally Officially recognized in 2010 Led by Steering Committee (20 members) Secretariat based at IFRC Represented on Gavi Board 1 seat CSO platforms in 24 countries

GAVI support to CSOs-Global level Steering Committee Vision, direction and funding of platforms SC secures resources for CSO country platforms SC designates Oversight Advisory Group Interface with Gavi Secretariat

GAVI Support to CSOs-in Country support Civil Society Platforms Country led-model Grant Manager (CRS/REPAOC) + Facilitating Organization (CSO) + Platform Each platform applies its own membership procedures Objective: Autonomous and sustainable CS Platforms that are a key partner to the Government to increase coverage rates Main activities: demand creation, awareness raising, etc. OAFRESS Regional francophone advocacy block 18 countries

Platforms: Strategic Objectives 1. Improved functionality Result 1 Improved governance and operations Result 2 Improved M&E accountability 2. Improved financial sustainability Result 1 Increased access to Gavi HSS funding Result 2 Increased capacity to secure diversified funding 3. Improved capacity to contribute to national health sector planning and coordination Result 1 - Platforms recognized by MoH as key partner Result 2 - Improved capacity to promote equity

Phased implementation of Gavi support in 24 countries Tier I Tier II Tier III Tier IV Phase 1 (2011) DRC; Kenya; Burkina Faso; Ghana; Ethiopia; Phase 2 (2013) Liberia; Guinea; Haiti; Nigeria; Chad; Uganda; Pakistan; India; Malawi; Phase 3 (2014) Sierra Leone; Togo; Cote d'ivoire; Mali; Zambia; Benin; Madagascar; Cameroun; Phase 4 (2016) CAR; Niger;

Gavi-eligible countries with Gavi CSO platforms

CSO engagement in national immunization/hss programs Operational support Demand creation, awareness raising activities; MCH/WIW weeks and campaigns Implement Gavi HSS activities to date Six platforms (Ethiopia, Ghana, Madagascar, Malawi, Mali and Zambia) are receiving Gavi HSS funding as a platform. Platform members in Ethiopia, Ghana, Kenya, Malawi, Mali and Togo are receiving Gavi HSS funding as individual CSOs

CSO engagement in national immunization/hss programs Policy and program management HSS proposal writing Development and evaluation of National Health plan and/or HSS grants Joint Appraisals 12 platforms in 2017 prepared JA with MoH Participation in ICCs and HSCCs all but South Sudan and Togo

Current Project phase Supposed to close-out in June 2018 (platforms closing activities in March) Costed extension until Dec. 2018 was given by Gavi for limited number of countries March 18 Red Cross National Societies are Platform members in 12 of the 24 countries OAG is currently working on different models for collaboration with Gavi after 2018, based on an analysis of the project progress and results

Challenges Technical capacity: different capacity levels within and across countries; + some members view the platform as a vehicle solely for resource mobilization and disbursement. Communication: Many platforms are doing great work but failing to produce high-quality, sharable communications. Showing CSO worth: Difficult to document how CSOs increase immunisation rates. Health management information systems: Gov t systems do not specifically collect CSO data. Sustainability: How to ensure that platforms continue to work after project finishes.

Lions Measles and Rubella Involvement 2010-Present Lions Clubs International is world s largest service organization. Founded 1917 1.4 million members 47,000 + Clubs 207 countries and geographical areas Partner in the Measles and Rubella Initiative since 2010 Local Lions developed wide-ranging, country-specific strategies to support measles and MR campaigns with advocacy and social mobilization. Lions enlist the support of local, regional and national leaders, in support of a measles and rubella control agenda. Partners with Gavi to mobilize funds for measles & rubella and to coordinate activities at the country level.

Country Level Activities 2010-2017 Participation in 60+ activities since 2010 Measles and MR Campaigns World Immunization Week $4,000,000+ in Lions Clubs International Foundation grants supporting in-country Lions activities.

Summary CSO platforms provide good opportunity to network with a broad civil society constituency Platforms have good capacity to mobilize communities to support immunization activities (routine and campaigns) Untapped resource to support measles Where possible, should link CSO platforms with partners like Lions, ARC, IFRC to support measles

Merci! Thank you! Danke! Obrigada! Shukran! Gavi CSO Steering Committee, Barcelona, October 2017